Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.
Stèfanie DickFrederique J VinkDaniëlle A M HeidemanBirgit I WitteChris J L M MeijerJohannes BerkhofPublished in: British journal of cancer (2021)
The use of FAM19A4/miR124-2 methylation and/or HPV genotyping in HPV-positive women with BMD can lead to a substantial reduction in the number of direct colposcopy referrals.